Ginkgo Bioworks Holdings, Inc. (DNA): auditor change — Ginkgo Bioworks replaces auditor: EY declines reappointment, Deloitte hired

Ginkgo Bioworks Holdings, Inc.

EY notified Ginkgo on March 8, 2024 it would not stand for reappointment as auditor for fiscal 2024; no disagreement cited.
Audit Committee appointed Deloitte & Touche as new independent auditor on March 13, 2024.
EY's reports for FY 2022 and 2023 were unqualified; no adverse opinions or scope limitations.
Material weaknesses in internal control over financial reporting were disclosed for both 2022 and 2023, as previously reported.
No disagreements or reportable events (other than the material weaknesses) occurred during the relevant periods.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Ginkgo Bioworks Holdings, Inc. engaged Deloitte & Touche LLP as its auditor.

Action: engagement
Auditor: Deloitte & Touche LLP

Exact text from the filing

On March 13, 2024, the Audit Committee appointed Deloitte & Touche LLP (“Deloitte”) as its new independent registered public accounting firm.

View on SEC.gov

19 auditor changes filed in the last 30 days. Browse all auditor changes →

Ginkgo Bioworks Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-011216

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.